CKD OTTO Pharmaceuticals is a joint venture company between Chong Kun Dang Pharm Corp., a leading Pharmaceutical company in Korea, with PT Otto Pharmaceutical Industries, a member of Indonesian leading Pharmaceutical company, MENSA Group. CKD OTTO Pharmaceuticals is a company specialize in oncology medicine. We are the first oncology manufacturer that obtain halal certification in Indonesia with excellent category in February 2019. Prior to this certification, we have receive GMP certificate from BPOM (National Agency of Food and Drug Control) Indonesia in September 2018. Our factory has fully technology transfer from Korea to produce sterile liquid injection and lyophilized powder. Equipped with the advanced and modern production facility, excellent manufacturing and testing equipment, our high-tech manufacturing plant is located in Lippo Cikarang Industrial Area, Indonesia. As CKD OTTO Pharmaceuticals specialization is anti-cancer drugs as known as oncology medicines, we cooperate with many hospitals throughout Indonesia to provide the best quality of oncology medicines. Our aim in the future is not only to reach the domestic market, but also to expand our market to ASEAN, MENA and EU countries. Implementing the same mission "Better Life through Better Medicine" as our major shareholder in Korea, we are eager to grow to become the number one pharmaceutical company in Indonesia.